Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Cash from Investing Activities: 2017-2021

Historic Cash from Investing Activities for ENDRA Life Sciences (NDRA) over the last 2 years, with Mar 2021 value amounting to -$45,000.

  • ENDRA Life Sciences' Cash from Investing Activities fell 101.34% to -$45,000 in Q1 2021 from the same period last year, while for Mar 2021 it was -$120,333, marking a year-over-year decrease of 82.47%. This contributed to the annual value of -$12,796 for FY2024, which is 48.24% up from last year.
  • Per ENDRA Life Sciences' latest filing, its Cash from Investing Activities stood at -$45,000 for Q1 2021, which was up 30.61% from -$64,850 recorded in Q4 2020.
  • In the past 5 years, ENDRA Life Sciences' Cash from Investing Activities ranged from a high of $11,867 in Q3 2020 and a low of -$100,000 during Q3 2018.
  • Over the past 3 years, ENDRA Life Sciences' median Cash from Investing Activities value was -$22,350 (recorded in 2020), while the average stood at -$23,418.
  • Data for ENDRA Life Sciences' Cash from Investing Activities shows a maximum YoY slumped of 326.61% (in 2020) over the last 5 years.
  • Over the past 5 years, ENDRA Life Sciences' Cash from Investing Activities (Quarterly) stood at -$7,862 in 2017, then reached -$100,000 in 2018, then reached -$38,357 in 2019, then tumbled by 69.07% to -$64,850 in 2020, then tumbled by 101.34% to -$45,000 in 2021.
  • Its Cash from Investing Activities stands at -$45,000 for Q1 2021, versus -$64,850 for Q4 2020 and $11,867 for Q3 2020.